These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10462376)

  • 1. Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration.
    Heller J; Sogni P; Tazi KA; Chagneau C; Poirel O; Moreau R; Lebrec D
    Hepatology; 1999 Sep; 30(3):698-704. PubMed ID: 10462376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular nitric oxide production during the development of two experimental models of portal hypertension.
    Gadano AC; Sogni P; Heller J; Moreau R; Bories PN; Lebrec D
    J Hepatol; 1999 May; 30(5):896-903. PubMed ID: 10365818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis.
    Moreau R; Barrière E; Tazi KA; Lardeux B; Dargère D; Urbanowicz W; Poirel O; Chauvelot-Moachon L; Guimont MC; Bernuau D; Lebrec D
    Hepatology; 2002 Nov; 36(5):1070-8. PubMed ID: 12395316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of nitric oxide in the reduction of protein kinase C-induced contractile response in aortae from rats with portal hypertension.
    Chagneau C; Tazi KA; Heller J; Sogni P; Poirel O; Moreau R; Lebrec D
    J Hepatol; 2000 Jul; 33(1):26-32. PubMed ID: 10905582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepant effects of inducible nitric oxide synthase modulation on systemic and splanchnic endothelial nitric oxide synthase activity and expression in cirrhotic rats.
    Malyshev E; Tazi KA; Moreau R; Lebrec D
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2195-201. PubMed ID: 18031380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOS3 is involved in the increased protein and arginine metabolic response in muscle during early endotoxemia in mice.
    Luiking YC; Hallemeesch MM; Lamers WH; Deutz NE
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1258-64. PubMed ID: 15644457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension.
    Pateron D; Tazi KA; Sogni P; Heller J; Chagneau C; Poirel O; Philippe M; Moreau R; Lebrec D
    Gastroenterology; 2000 Jul; 119(1):196-200. PubMed ID: 10889169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac impairment and nitric oxide synthase activity in the chronic portal vein-stenosed rat.
    Battarbee HD; Zavecz JH; Grisham MB; Maloney RE; Chandler LJ; Mercer JW; Cady FM
    Am J Physiol; 1999 Feb; 276(2):G363-72. PubMed ID: 9950809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis.
    Biecker E; Neef M; Sägesser H; Shaw S; Koshy A; Reichen J
    Liver Int; 2004 Aug; 24(4):345-53. PubMed ID: 15287858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of NOS2 and NOS3 in renal protein and arginine metabolism during early endotoxemia in mice.
    Luiking YC; Hallemeesch MM; Lamers WH; Deutz NE
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F816-22. PubMed ID: 15547116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOS2 deficiency increases intestinal metabolism both in nonstimulated and endotoxemic mice.
    Vissers YL; Hallemeesch MM; Soeters PB; Lamers WH; Deutz NE
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G747-51. PubMed ID: 14656712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dependence of matrix metalloproteinase-mediated vascular hyporeactivity caused by lipopolysaccharide.
    Cena J; Lalu MM; Rosenfelt C; Schulz R
    Eur J Pharmacol; 2008 Mar; 582(1-3):116-22. PubMed ID: 18242597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metalloendopeptidase inhibition regulates phosphorylation of p38-mitogen-activated protein kinase and nitric oxide synthase in heart after endotoxemia.
    Gupta A; Sharma AC
    Shock; 2003 Oct; 20(4):375-81. PubMed ID: 14501953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of inducible nitric oxide synthase decreases mesenteric vascular responsiveness in portal hypertensive mice.
    Bexis S; Vandeputte C; McCormick PA; Docherty JR
    Eur J Pharmacol; 2004 Sep; 499(3):325-33. PubMed ID: 15381055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid attenuates inducible nitric oxide synthase (NOS2) activation in cultured rat cardiac myocytes and microvascular endothelial cells.
    Grosjean S; Devaux Y; Seguin C; Meistelman C; Zannad F; Mertes PM; Kelly RA; Ungureanu-Longrois D
    J Mol Cell Cardiol; 2001 May; 33(5):933-45. PubMed ID: 11343416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of HMG-CoA reductase inhibition by simvastatin on vascular dysfunction induced by lipopolysaccharide in rats.
    Alvarez de Sotomayor M; Vega S; Mingorance C; Marhuenda E; Herrera MD
    Pharmacology; 2008; 82(2):89-96. PubMed ID: 18509252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
    Xu J; Cao H; Liu H; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha regulates nitric oxide synthase expression in portal hypertensive gastric mucosa of rats.
    Ohta M; Tarnawski AS; Itani R; Pai R; Tomikawa M; Sugimachi K; Sarfeh IJ
    Hepatology; 1998 Apr; 27(4):906-13. PubMed ID: 9537427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential changes in redox status and nitric oxide synthases expression in the liver after bile duct ligation.
    Vázquez-Gil MJ; Mesonero MJ; Flores O; Criado M; Hidalgo F; Arévalo MA; Sánchez-Rodríguez A; Tuñón MJ; López-Novoa JM; Esteller A
    Life Sci; 2004 Jun; 75(6):717-32. PubMed ID: 15172180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nitric oxide and protein kinase C in lipopolysaccharidemediated vascular hyporeactivity.
    Karimi G; Fatehi Z; Gholamnejad Z
    J Pharm Pharm Sci; 2006; 9(1):119-23. PubMed ID: 16849013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.